Cargando…
Effects of KDT501 on Metabolic Parameters in Insulin-Resistant Prediabetic Humans
CONTEXT: KDT501 is an isohumulone drug that has demonstrated beneficial effects on metabolic parameters in mice. OBJECTIVE: This study was intended to examine potential improvements in metabolism in humans. DESIGN AND SETTING: Changes in carbohydrate and lipid metabolism, along with inflammatory mar...
Autores principales: | Kern, Philip A., Finlin, Brian S., Ross, Dorothy, Boyechko, Tania, Zhu, Beibei, Grayson, Neile, Sims, Robert, Bland, Jeffrey S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5686568/ https://www.ncbi.nlm.nih.gov/pubmed/29264518 http://dx.doi.org/10.1210/js.2017-00202 |
Ejemplares similares
-
The Influence of a KDT501, a Novel Isohumulone, on Adipocyte Function in Humans
por: Finlin, Brian S., et al.
Publicado: (2017) -
KDT501, a Derivative from Hops, Normalizes Glucose Metabolism and Body Weight in Rodent Models of Diabetes
por: Konda, Veera R., et al.
Publicado: (2014) -
Effect of Rifaximin Treatment on Endotoxemia and Insulin Sensitivity in Humans
por: Finlin, Brian S, et al.
Publicado: (2019) -
Improved β-cell function leads to improved glucose tolerance in a transgenic mouse expressing lipoprotein lipase in adipocytes
por: Memetimin, Hasiyet, et al.
Publicado: (2022) -
Insulin-resistant subjects have normal angiogenic response to aerobic exercise training in skeletal muscle, but not in adipose tissue
por: Walton, R Grace, et al.
Publicado: (2015)